Investor Presentation • May 19, 2020
Investor Presentation
Open in ViewerOpens in native device viewer




This document has been prepared by Datalogic S.p.A. (the "Company") for use during meetings with investors and financial analysts and is solely for information purposes. The information set out herein has not been verified by an independent audit company. Neither the Company nor any of its subsidiaries, affiliates, branches, representative offices (the "Group"), as well as any of their directors, officers, employees, advisers or agents (the "Group Representatives") accepts any responsibility for/or makes any representation or warranty, express or implied, as to the accuracy, timeliness or completeness of the information set out herein or any other related information regarding the Group, whether written, oral or in visual or electronic form, transmitted or made available.
This document may contain forward-looking statements about the Company and/or the Group based on current expectations and opinions developed by the Company, as well as based on current plans, estimates, projections and projects of the Group. These forward-looking statements are subject to significant risks and uncertainties (many of which are outside the control of the Company and/or the Group) which could cause a material difference between forward-looking information and actual future results. The information set out in this document is provided as of the date indicated herein. Except as required by applicable laws and regulations, the Company assumes no obligation to provide updates of any of the aforesaid forward-looking statements. Under no circumstances shall the Group and/or any of the Group Representatives be held liable (for negligence or otherwise) for any loss or damage howsoever arising from any use of this document or its contents or otherwise in connection with the document or the aforesaid forward-looking statements.
This document does not constitute an offer to sell or a solicitation to buy or subscribe to Company shares and neither this entire document or a portion of it may constitute a recommendation to effect any transaction or to conclude any legal act of any kind whatsoever.
This document may not be reproduced or distributed, in whole or in part, by any person other than the Company. By viewing and/or accepting a copy of this document, you agree to be bound by the foregoing limitations.



Global technology leader in the automatic data capture and process automation markets, in the Retail, Manufacturing, Transportation & Logistics, and Healthcare industries
Founded in 1972, listed on the Italian Stock Exchange since 2001


1,200+ patents filed and more than 350 in approval

10 Manufacturing and Repair facilities in: Italy, US, Brazil, Hungary, Slovakia, Vietnam and Australia

500 engineers in 11 R&D centers and 3 DL Labs in: Italy, USA, Vietnam, China, and Germany

3,074 Employees in 28 countries: 20% Americas, 57% EMEAI, 23% APAC





Sales CAGR 2001-2019 +10%

-30%
-25%
-5%
0%
5%
15%
0
100
200
300
400
500
600
700
800
900
1000


Market Segment: STAR MTA
Reuters Code: DAL.MI
Bloomberg Code: DAL IM
Outstanding Shares: 58,446,491
Share Par-Value: 0.52 Euro each
Ticker: DAL
Price (May 15, 2020): 10.87 Euro
Market Cap (May 15, 2020): 635 mln Euro
Auditing Company: Deloitte






TAM: ~ 14 bln USD
needs of End Users in the following Industries: Retail, T&L, Factory Automation,
EMEA and become a strong
with a growing presence in

▪ Wide range of products able to fulfill our Customers' needs for both data collection and process automation and providing end-to-end solutions across the entire flow of operations





Most complete offer of barcode readers: from retail to industrial scanners, from hand held to mobile

Undisputed leadership on barcode readers
Complementary/Open doors products in the MFG Industry




Self-Shopping Mark & Read Dimensioning & Weighing Systems


Complete Traceability Mark & Trace




Machine learning technology adoption to be ready for the next checkout POS investment cycle
The main international players are experimenting new products and solutions to satisfy new shoppers' needs and improve efficiency of their operations: click & collect, drive & collect, online verification, in real time, of the availability and exact position within the shelves of the products in the store or in the warehouse, assisted selling, self scanning and self check-out






Datalogic is providing multi-product portfolio to serve all the major manufacturing clients: Automotive, Food and Beverage, Automated Machinery and Electronics, and Intralogistics
Market trends




* Source: IoT Analytics
** Source: International Federal of Robotics (IFR) data and Loup Ventures

Historically leader in stationary industrial scanners and sorting solutions Datalogic has a big opportunity to seize in the T&L mobility space
Growth is driven by E-commerce: high speed sorting, ability to manage any size of parcel, and high flexibility. E-Commerce is driving the industry growth


Datalogic is the sole company providing unique product features for the HC industry such as: Anti-microbial enclosures, Inductive charging technology for battery recharge, and Green spot good match to ensure positive medicine-patient identification
Hospital investments in patient safety are expected to grow significantly in the next 5 years: technology adoption to secure proper patients traceability and drug administration



❑ FY2019 Vitality index of 20.1% of total sales compared to 15.0% in 2018. Q1 2020 Vitality Index* continues
improving to 22.2%
❑ 2019 R&D spending** amounted to approximately 65 m€ 10.6% on turnover, in line with the Group's strategy on
innovation
❑ 20 new patents filed in 2019 reaching 1,230 patents


▪ Keep focus on all of our 4 verticals
▪ RTL (\$ 4 bln): check out evolution, cross sell mobile, watch distribution centers carefully

M&A
▪ Mobile: increase market share completing and widening our offer of portable data terminal (PDT) and
▪ Continuous improvement of core technology (bar code reading) e.g. optics, decoding
▪ Selected target to accelerate our growth and/or to acquire critical technologies







* Total R&D spent Including capitalized R&D

❑ Retail: tough comparison due to major Fixed Retail Scanner rollouts with large clients in EMEAI in 2018. Positive
❑ Manufacturing: double digit growth in North America, partially offset by slowdown in Automotive (EMEAI) and in

| € m |
FY 2019 | FY 2018 | Var % vs. FY 2018 |
Constant FX |
|---|---|---|---|---|
| Retail | 265.7 | 278.0 | (4.4%) | (7.1%) |
| Manufacturing | 157.4 | 169.9 | (7.4%) | (8.6%) |
| Transportation & Logistics | 75.0 | 68.6 | 9.5% | 6.6% |
| Healthcare | 20.0 | 20.1 | (0.3%) | (3.2%) |
| Channel (Unallocated) | 50.0 | 49.2 | 1.8% | 0.4% |
| Total DL Business | 568.1 | 585.7 | (3.0%) | (5.2%) |
| Solution Net Systems | 29.1 | 28.3 | 2.6% | (2.6%) |
| Informatics | 18.7 | 19.6 | (4.3%) | (9.3%) |
| Intra division | (3.4) | (2.6) | ||
| Total Datalogic | 612.5 | 631.0 | (2.9%) | (5.3%) |
❑ EMEAI: growth in HC and T&L partially offsetting Retail downturn due to major FRS roll outs in 2018.
❑ North America: revenues show positive growth across all verticals. Excluding SNS and INF, NA Business grew 8.8%.


| Var % vs. FY 2018 |
Constant FX | |||
|---|---|---|---|---|
| EMEAI | 309.6 | 324.8 | (4.7%) | (5.9%) |
| North America | 219.4 | 205.9 | 6.6% | 1.5% |
| APAC | 67.4 | 83.8 | (19.6%) | (20.1%) |
| Latin America | 16.1 | 16.5 | (2.5%) | (4.3%) |
| Total Datalogic | 612.5 | 631.0 | (2.9%) | (5.3%) |


| € m Revenues Gross Margin Operating expenses % on Revenues * EBITDA % Ebitda margin |
% on Revenues | FY 2019 612.5 293.1 |
FY 2018 631.0 306.0 |
Reported (2.9%) |
F X (5.3%) |
▪ Revenues |
|---|---|---|---|---|---|---|
| down 2.9% to €612.5 m (-5.3% Net FX); | ||||||
| ▪ Gross Margin at 47.9%, flat Net FX |
||||||
| 47.9% | 48.5% | -0.6 pp | +0.0 pp | ▪ Operating expenses at €220.0 m: |
||
| (220.0) | (215.6) | ✓ R&D on revenues in line with previous year |
||||
| (35.9%) | (34.2%) | -1.8 pp | ||||
| 95.0 | 105.5 | ✓ S&D on revenues from 17.8% to 19.7% due |
||||
| 15.5% | 16.7% | -1.2 pp | -0.6 pp | to the carry over effects of commercial | ||
| EBIT | 65.5 | 83.5 | organization investments from last year | |||
| % Ebit margin | 10.7% | 13.2% | -2.5 pp | -2.0 pp | ||
| Net Income | 50.3 | 62.2 | ✓ G&A and other items kept under control |
|||
| % on Revenues | 8.2% | 9.9% | -1.6 pp | -1.2 pp | ||
| EUR/USD FX Exchange Rate | 1.12 | 1.18 | from 6.6% to 6.5% |


€ m



€ m


▪ Health and safety of our people is a priority. Sound health and safety protocols established for all facilities
▪ Strong commitment to guarantee optimal continuity to our customers and partners, whilst working

▪ Donations and community support by providing to Italian hospitals antimicrobial devices, disinfectant
▪ Activation of Government social schemes and other employment support tools ▪ Sound Cost reduction plan on any discretionary spending while driving commercial
• Strong Financial Structure with Net Debt of €21.0 m. Additional credit lines available providing significant headroom to secure future investment for growth in uncertain environment.


Memor 10 Memor 20 Memor 1 Joya






AV7000 AV500 AV900








| € m | Q1 2020 | Q1 2019 | Variance Reported |
Constant F X |
▪ Revenue -14,2% driven by large roll-outs in Q12019, |
|---|---|---|---|---|---|
| Revenues | 124.2 | 144.6 | (14.2%) | (15.0%) | T&L projects completion and overall Covid effect. |
| Gross Margin | 58.0 | 70.2 | ▪ Gross Margin at 46.7%, decrease mainly due to |
||
| % on Revenues | 46.7% | 48.5% | -1.8 pp | -1.3 pp | volumes and lower absorption of fixed costs. Price |
| Operating expenses | (56.7) | (53.9) | |||
| % on Revenues | (45.7%) | (37.3%) | -8.4 pp | substantially in line with past trend | |
| Adjusted EBITDA | 7.3 | 21.6 | ▪ Operating expenses at €56.7 m: |
||
| % Adj. Ebitda margin | 5.9% | 15.0% | -9.1 pp | -8.5 pp | |
| EBIT | (1.2) | 14.8 | ✓ R&D expenses increased by 18.3% for strategic |
||
| % Ebit margin | (1.0%) | 10.2% | -11.2 pp | -10.7 pp | investments |
| Net Income | (4.3) | 12.6 | ✓ S&D €2.6m savings vs LY net of 2019 one-offs |
||
| % on Revenues | (3.4%) | 8.7% | -12.1 pp | -11.6 pp | |
| EUR/USD FX Exchange Rate | 1.10 | 1.14 | ✓ G&A expenses in line with previous year |
||
| ▪ Financial charges impacted by unfavorable FX and |
|||||
| negative fair value on cash equivalents investments at | |||||
| the lows of Q1 financial market |


€ m




€ m

▪ Given the current crisis relating to the Covid-19, and the timing of a possible recovery, the Group believes it is not yet possible to estimate the overall impact it will have on the full year. The evolution of the pandemic, the resolutions of authorities regarding lockdowns, as well as market reactions and possible recessions imply negative growth forecasts for the first half of 2020 and
▪ The Group is implementing measures to mitigate the financial impact of Covid-19, focusing on solid cost reduction plans, while
▪ Despite the expected short-term negative trend, the solid economic and financial fundamentals will lead Datalogic to grow again

IR Manager Vincenza Colucci CDR Communication Srl Tel. +39 335 6909547 [email protected]
IR Assistant Daniela Giglioli Tel. +39 051 3147109 Fax +39 051 3147205 E-mail [email protected]
[email protected] Via Candini, 2 40012 Lippo di Calderara di Reno Bologna – Italy
May 26, 2020 Virtual STAR Conference Milan
June 4, 2020 Shareholders' Meeting
www.datalogic.com

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.